Based on these mechanistic intersections, we hypothesized that FGFR inhibition may enhance the pro-apoptotic effects of CBD in CRC cells, particularly in tumors with high FGFR2 expression. This evidence concerns the gene FGFR2 and colorectal carcinoma.